HealthDay News — Empagliflozin initiation is not associated with incident nonproliferative diabetic retinopathy (NPDR) compared with initiation of a dipeptidyl peptidase 4 inhibitor (DPP4i), according ...

Diabetic retinopathy (DR) remains the leading cause of vision loss and blindness in people of working age, in spite of the fact that current treatments are effective. Vision loss occurs in DR due ...

Ip, MD, discusses the available treatments for nonproliferative diabetic retinopathy. Ip said about 50% of responders to an American Society of Retina Specialists survey reported that they were ...

The primary endpoint will be a reduction of three steps or more on the binocular diabetic retinopathy ... of moderate to severe nonproliferative diabetic retinopathy. According to a company ...

Diabetic neuropathy refers to nerve damage due to diabetes. When it affects the feet, healthcare professionals call it peripheral neuropathy. It usually affects both feet at the same time, as well ...

People with type 2 diabetes who are taking empagliflozin are less likely to develop diabetic retinopathy compared to those not using the drug, new evidence has revealed. A recent study from the ...

The best diabetes medication for kidney disease can vary depending on the severity of your kidney damage. You may need a medication that doesn’t require dose adjustment based on your kidney ...